Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 March 2020

Date

Monday, 9 March 2020, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

Update: This meeting of the PRAC will be held virtually only, with no physical presence of delegates or other visitors at the EMA building.

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

Share this page